Cecilia Flores' work focuses on the dysfunction of the dopaminergic system, a brain system important in reward, motor, and cognitive functions.

Lalit Srivastava, has conducted research on schizophrenia and dopamine, a brain chemical implicated in its development.

Michael Meaney examines the molecular mechanisms by which maternal care alters gene expression.

Marc Laporta, MD, develops international collaborative ventures  in the area of emergencies and disasters for the Americas.

As a clinician, Johanne Renaud holds the title of medical chief for the youth section of the Douglas Institute’s Depressive Disorders Program.

Reut Gruber examines the association between sleep and attention in children and adolescents and the genetics of sleep.

Tak Pan Wong studies the impact of stress on the brain and evaluates how this relates to behaviour, learning and memory.

Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Claire-Dominique Walker investigates the consequences of early stress on brain development and the neuroendocrine responses to stress.